Jiajie Yu
6PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 04, 2026
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fenebrutinib and Effect on the QT/QTc Interval in Healthy Participants.Yan Xu, Sonoko Kawakatsu, Denison Kuruvilla
|Apr 14, 2025
Predicting survival in prospective clinical trials using weakly-supervised QSP.Matthew West, Kenta Yoshida, Jiajie Yu
|Jun 04, 2024
Mass Balance, Metabolic Pathways, Absolute Bioavailability, and Pharmacokinetics of Giredestrant in Healthy Subjects.Smita Kshirsagar, Ya-Chi Chen, Jiajie Yu
|Feb 02, 2024
UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in Giredestrant Exposure.Vikram Malhi, Malgorzata Nowicka, Ya-Chi Chen
|Nov 29, 2023
Optimizing Early-stage Clinical Pharmacology Evaluation to Accelerate Clinical Development of Giredestrant in Advanced Breast Cancer.Vikram Malhi, Priya Agarwal, Mary R Gates
|Nov 03, 2023
Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer.Komal L Jhaveri, Meritxell Bellet, Nicholas C Turner
Pageof 1
Frequent Collaborators
2 joint publications
Tom De Bruyn
2 joint publications
Mary R Gates
2 joint publications
Jennifer Eng-Wong
1 joint publications
Lin Pan
1 joint publications
Meritxell Bellet
1 joint publications
Nicholas C Turner
1 joint publications
Sherene Loi
1 joint publications
Aditya Bardia
1 joint publications
Valentina Boni
1 joint publications
Tomas G Neilan
